Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian Goff currently holds 13,300 shares of ALEXION PHARMACEUTICALS, INC. (ALXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Goff has been a net seller of ALXN stock. They have purchased $0 and sold $3.0M worth of shares.
Brian Goff's most recent insider trade was on Jun 9, 2026, when they sold 13,300 shares at $0.00 per share.
Brian Goff serves as Executive at ALEXION PHARMACEUTICALS, INC. (ALXN). They have executed 61 insider transactions totaling $3.0M over their tenure at the company.
Brian Goff holds the position of Executive at ALEXION PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Brian Goff has shown a selling trading pattern, with $0 in total purchases and $3.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brian Goff was on Dec 16, 2020, when they sold $2.9M worth of ALXN shares. This transaction involved 18,134 shares at $157.96 per share.
Brian Goff currently owns 13,300 shares of ALEXION PHARMACEUTICALS, INC. (ALXN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian Goff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian Goff has 61 Form 4 filings on record as an insider at ALEXION PHARMACEUTICALS, INC..
Set alerts for Brian Goff and 40,000+ other insiders.